Evidence map›Paper›PMID 39005601›Full record

ArticleIranian journal of microbiology2024

Antibiotyping, RAPD- and ERIC-PCR fingerprinting of

Ni Nengah Dwi Fatmawati, Felicia Aviana, Ronny Maharianto, Gede Ngurah Rsi Suwardana, Ni Made Adi Tarini, I Nengah Sujaya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Multidrug-ResistantMicroorganisms · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ni Nengah Dwi FatmawatiDepartment of Clinical Microbiology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.
Felicia AvianaDepartment of Clinical Microbiology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.
Ronny MahariantoDepartment of Clinical Microbiology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.
Gede Ngurah Rsi SuwardanaDepartment of Clinical Microbiology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.
Ni Made Adi TariniDepartment of Clinical Microbiology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.
I Nengah SujayaDepartment of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Materials and Methods: The antibiograms of 46 Results: About 71.7% of the isolates were ESBL-producers, and more than 80% of isolates were susceptible to amikacin, ertapenem, and meropenem. The antibiotyping produced 32 diverse types with DI = 0.964. In addition, the RAPD-PCR produced 47 different types with DI = 1, while ERIC-PCR was 46 (DI=0.999). Conclusion: Antibiotyping, RAPD- and ERIC-PCR showed powerful discrimination power among the isolates, supported the diversity of

Indexed as

AntibiogramDNA fingerprintingKlebsiella pneumoniaMolecular typingTransmission

Identifiers

PMID39005601
PMCPMC11245350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.